Á lódáil...
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
OBJECTIVE: To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity. METHODS: In this prospective, single-arm, dose-titration study (NCT01603459), patients (18–80 years) wi...
Na minha lista:
Foilsithe in: | Neurology |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Lippincott Williams & Wilkins
2017
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5379931/ https://ncbi.nlm.nih.gov/pubmed/28283596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003789 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|